Latha Dulipsingh, MD, Endocrinology, Hartford, CT, The Hospital of Central Connecticut at Bradley Memorial

LathaDulipsinghMD

Endocrinology Hartford, CT

Diabetes, Lipid Metabolism

Associate Professor, Medicine, University of Connecticut SOM

Dr. Dulipsingh is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dulipsingh's full profile

Already have an account?

Education & Training

  • University of Connecticut
    University of ConnecticutFellowship, Endocrinology, Diabetes and Metabolism, 1995 - 1998
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1992 - 1995
  • Madras Medical College
    Madras Medical CollegeClass of 1989

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1994 - 2021
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
  • Diabetes Recognition Program National Committee for Quality Assurance, 2011-2014
  • Fellow (FACP) American College of Physicians, 2002
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SAT-184 Silent Pheochromocytoma Complicated by Adrenal Insufficiency After Unilateral Adrenalectomy, Journal of the Endocrine Society, Volume 4, Issue Supplement_1, Ap...  
    Hassaan B Aftab, MD, Parvathy Madhavan, MD, Latha Dulipsingh, MBBS,MD, Endocrine Journal
  • Short-Term Risk of Endocrinopathies Following Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer. Connecticut Medicine 2019; 83 (10) 503-508 3.  
    Dulipsingh L, Dermesropian R, Purushotaman A, Wakefield D, Rathmann J, Vredenburgh J., Connecticut Medicine

Press Mentions

  • Trinity Health of New England Says COVID-19 Convalescent Plasma Trial Shows Potential
    Trinity Health of New England Says COVID-19 Convalescent Plasma Trial Shows PotentialMay 1st, 2020
  • Trinity Health of New England Seeks Blood Plasma from Recovered COVID-19 Patients
    Trinity Health of New England Seeks Blood Plasma from Recovered COVID-19 PatientsApril 23rd, 2020
  • In Experimental Treatments, Connecticut Hospitals Are Using Blood Plasma from Recovered Coronavirus Patients to Try and Help Those Who Are Still Sick
    In Experimental Treatments, Connecticut Hospitals Are Using Blood Plasma from Recovered Coronavirus Patients to Try and Help Those Who Are Still SickApril 14th, 2020
  • Join now to see all

Committees

  • Chair, Institutional Review Board of Trinity Health Of New England 2014 - Present

Professional Memberships

Hospital Affiliations